Latest news

Our mission is to revolutionise synthetic gene synthesis to facilitate the fast-growing and exciting field of synthetic biology.

Evonetix establishes scientific advisory board

Evonetix establishes scientific advisory board

EVONETIX LTD (‘Evonetix’), the Cambridge-based company pioneering an innovative approach to scalable and high-fidelity gene synthesis, today announces the formation of its scientific advisory board (SAB). Evonetix has appointed Prof David Klenerman FMedSci FRS and...

read more
Evonetix named Best Synthetic Biology Company at OBN Awards

Evonetix named Best Synthetic Biology Company at OBN Awards

EVONETIX LTD (‘Evonetix’), the Cambridge-based company pioneering an innovative approach to scalable and high-fidelity gene synthesis, has received the award for “Best Emerging Synthetic Biology Company” at the 10th Anniversary of the Oxford Bioscience Network (OBN)...

read more

Evonetix in the news

European Biopharmaceutical Review

April, 2019

The Authenticity of Synthetics

Original article.

Engineering Biology (Institution of Engineering and Technology)

February, 2019

Thermofluidic chip containing virtual thermal wells

Original article.

MedNous

January, 2019

Managing European Medical Innovation

Original article.

BREAKTHROUGH

December, 2018

Synthetic biology and plant agriculture.

Original article.

Cambridge Independent Science and Technology Awards

November, 2018

Evonetix – START-UP OF THE YEAR – 2018 Highly Commended.

Original article.